Skip to content
Sign inOpen the app
Artwork for The Chain: Protein Engineering Podcast
The Chain: Protein Engineering Podcast · January 13 · 44 min

Episode: 81 - Laszlo Radvanyi on Pushing Boundaries in Cancer Immunotherapy Research

How has immunotherapy evolved in the last decade? In this episode of The Chain, Laszlo Radvanyi, professor of immunology at the University of Toronto, discusses his years-long research on cancer immunotherapy, including his time at MD Anderson, with host Rakesh Dixit. He shares his thoughts on agonist antibodies, the true breakthroughs that are moving the needle for patients, reducing the CD-28 pathway so that it doesn’t produce cytokine toxins, and what is the next frontier in immunotherapy. Links from this episode: EpiVax University of Toronto, Department of Immunology University of Toronto

0:00 · Opening And Guest Introduction-44:15
Play in podnod
Transcript file

transcript

No transcript — this publisher did not publish one.

show notes

How has immunotherapy evolved in the last decade? In this episode of The Chain, Laszlo Radvanyi, professor of immunology at the University of Toronto, discusses his years-long research on cancer immunotherapy, including his time at MD Anderson, with host Rakesh Dixit. He shares his thoughts on agonist antibodies, the true breakthroughs that are moving the needle for patients, reducing the CD-28 pathway so that it doesn’t produce cytokine toxins, and what is the next frontier in immunotherapy. 

Links from this episode:  
EpiVax
University of Toronto, Department of Immunology 
University of Toronto 

 

links3

chapters

9 chapters

more episodes

All episodes